Key result
Contemporary high-risk PE management linked to ~69% less major bleeding without 30-day mortality benefit.
Why the study?
Little is known regarding trends of treatment strategy and mortality in high-risk pulmonary embolism patients following changes in ESC guidelines.
Observational (n=52)
p-value: p=0.303
Mortality trends in high-risk PE coincided with less thrombolysis and more ECMO; leaves open whether shifts improved outcomes or reflect confounding.
Background Thrombolysis has been recommended for high-risk pulmonary embolism (PE) in ESC guidelines, used as a reference in Japan. Recently, indication of thrombolysis for acute PE has been limited with recent guideline revision. Little is known regarding trends of treatment strategy and mortality in high-risk PE patients. Purpose To clarify temporal trends of treatment strategy and short-term outcomes in high-risk PE patients. Methods A retrospective analysis of therapeutic interventions and short-term outcomes was performed for 52 consecutive high-risk PE patients including cardiac arrest. According to timing of ESC guidelines update (2000, 2008 and 2014), patients were divided into four time periods: 1992 to 2000, 2001 to 2008, 2009 to 2014, and 2015 to 2018. Results Mean age and proportion of male were not different over the period. Nosocomial case decreased from 100% to 25% (p<0.01). Postoperative cases (relative contraindication for thrombolysis) included 43% of all patients. Cardiac arrest and VA-ECMO use were 42% and 21% of all patients. Any thrombolytic therapy including catheter-directed intervention showed a non-significant decrease trend (92%-87%-71%-44%, p=0.067). Temporary or retrieval IVC filter insertion showed a significant downward trend (36%-80%-54%-22%, p=0.025). The entire study 30-day mortality was 23%. There was no significant difference in 30-day mortality over the periods (14%-27%-14%-44%, p=0.303). However, major bleeding decreased significantly (71%-40%-7%-22%, p=0.004) (Table). Table 1 1992–2000 (n=14) 2001–2008 (n=15) 2009–2014 (n=14) 2015–2018 (n=9) p Age (years) 54±12 59±17 64±13 65±16 0.224 Male 29% 13% 29% 44% 0.269 Any thrombolytic therapy 92% 87% 71% 44% 0.067 Catheter-directed therapy 86% 87% 71% 0% <0.01 with thrombolytics (92%) (83%) (90%) without thromboloytics (8%) (17%) (10%) Only intravenous thrombolysis 8% 7% 7% 44% 0.038 Temporary/retrieval IVC filter 36% 80% 54% 22% 0.025 ICU stay (days) 15±14 10±18 5±4 8±8 0.206 30-day mortality 14% 27% 14% 44% 0.303 Major bleeding 71% 40% 7% 22% 0.004 Conclusion The temporal analysis identified a decreased trend in any thrombolytic therapy and IVC filter insertion in high-risk PE. The study also found a decreasing trend in major bleeding.
No takes yet. Share an insight, caveat, or question.
Hosokawa et al. (2019) conducted an observational in High-risk pulmonary embolism (n=52). Temporal trends (1992-2018) was evaluated on 30-day mortality (p=0.303). Over 28 years, treatment of high-risk pulmonary embolism showed a significant reduction in major bleeding (71% to 22%, P=0.004), but no significant difference in 30-day mortality (P=0.303).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: